|
| Status |
Public on Jul 04, 2016 |
| Title |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by array
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
May 11, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
Medhanie Assmelash Mulaw |
| E-mail(s) |
medhanie.mulaw@uni-ulm.de
|
| Organization name |
University of Ulm
|
| Street address |
Albert-Einstein-Allee 11
|
| City |
Ulm |
| ZIP/Postal code |
89081 |
| Country |
Germany |
| |
|
| Platforms (4)
|
| GPL6246 |
[MoGene-1_0-st] Affymetrix Mouse Gene 1.0 ST Array [transcript (gene) version] |
| GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
| Samples (36)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE81174 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [Affymetrix] |
| GSE81321 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [ChIP-Seq] |
| GSE81328 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] |
| GSE81329 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq mouse] |
|
| Relations |
| BioProject |
PRJNA321303 |
Less...
More...